Other | Center for Medical Cannabis | Utah Department of Health and Human Services
Utah medical cannabis guidelines provide evidence-based clinical recommendations for healthcare professionals. These guidelines help clinicians navigate cannabis therapeutics safely. They represent a key resource for state-level cannabis policy and…
Evidence-Based Guidelines for Medical Cannabis: Utah Department of Health
The 2026 cannabis clinical guidelines provide a framework for medical cannabis use in Utah. These evidence-based guidelines aim to standardize clinical practice and improve patient care. Utah's approach reflects a careful balance of research and…
FOX4 – New Study on Smoking Cannabis Effects from Washington State University
The smoking cannabis effects study from Washington State University highlights the importance of research quality in cannabis medicine. Without full study details, clinical commentary remains limited. This study emphasizes the need for complete…
Is Trulieve Cannabis Using Terpene-Focused Vapes to Sharpen Its Maryland Moat?
Terpene-focused cannabis products are gaining popularity as companies like Trulieve market vape formulations with specific terpene profiles. While patient interest in terpenes grows, clinical evidence supporting targeted therapeutic effects remains…
Expanded Use of CBD in Medical Research Gets FDA Approval – KTALnews.com
FDA approval of expanded CBD research protocols marks a significant advancement in medical research. This development enhances the quality and scope of clinical evidence available for CBD. Expanded CBD research protocols will help guide better patient…
Ensuring CBD Gummy Patient Safety for Anxiety
CBD gummy patient safety is crucial when considering treatment for anxiety disorders. Clinicians must evaluate product quality and dosing consistency to ensure safe use. Evidence-based information guides patient care decisions regarding CBD gummies for…
Dietary Bioactives in Alzheimer’s Disease: A Critical Appraisal of Clinical Trials and Future Directions
This review critically examines dietary bioactives alzheimer s disease clinical trials, focusing on cannabinoids and other compounds. It provides clinicians with an evidence-based assessment to distinguish promising treatments from marketing claims.…
A&S scholars sharing their expertise in the media | Faculty of Arts & Science
This article highlights academic cannabis media coverage featuring Faculty of Arts & Science scholars sharing their expertise. It focuses on emerging cannabis research and clinical developments. The coverage provides valuable insights into cannabis…
More than a decade after recreational cannabis was legalized in Washington, a new survey …
Post-legalization cannabis surveillance is critical for understanding health outcomes after Washington legalized recreational cannabis. This survey examines population health impacts more than a decade later. Clinical interpretation requires rigorous…
Exploring Neuroprotective Cannabis Clinical Trials and Their Impact
Neuroprotective cannabis clinical trials are advancing research into treatments for neurological disorders. These trials explore cannabis compounds' potential to protect nerve cells. Understanding clinical evidence helps guide safe and effective use.